Hoyoung M Maeng (Hoyoung Maeng)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

High Throughput Sequencing

Top Venues

Journal for immunotherapy of cancer

Journal of immunology (Baltimore, Md. : 1950)

This page only lists publications with an associated author ORCID identifier.

Publications

William Becker, Purevdorj B Olkhanud, Noriko Seishima, Paloma A Moreno, Katherine C Goldfarbmuren, Hoyoung M Maeng, David M Moore
Second-generation checkpoint inhibitors and Treg depletion synergize with a mouse cancer vaccine in accordance with tumor microenvironment characterization. Journal for immunotherapy of cancer 12 (7) (2024)
William Becker, Purevdorj B Olkhanud, Noriko Seishima, Paloma A Moreno, Katherine C Goldfarbmuren, Hoyoung M Maeng, David M Moore
Second-generation checkpoint inhibitors and Treg depletion synergize with a mouse cancer vaccine in accordance with tumor microenvironment characterization. Journal for immunotherapy of cancer 12 (7) (2024)
Jihye L Golino, Xin Wang, Hoyoung M Maeng, Changqing Xie
Revealing the Heterogeneity of the Tumor Ecosystem of Cholangiocarcinoma through Single-Cell Transcriptomics. Cells 12 (6) (2023)
Jihye L Golino, Xin Wang, Hoyoung M Maeng, Changqing Xie
Revealing the Heterogeneity of the Tumor Ecosystem of Cholangiocarcinoma through Single-Cell Transcriptomics. Cells 12 (6) (2023)
Jihye L Golino, Xin Wang, Hoyoung M Maeng, Changqing Xie
Revealing the Heterogeneity of the Tumor Ecosystem of Cholangiocarcinoma through Single-Cell Transcriptomics. Cells 12 (6) (2023)
Wei-Zen Wei, Heather M Gibson, Jennifer B Jacob, Jeffrey A Frelinger, David M Moore, Hoyoung M Maeng, Gregory Dyson, Joyce D Reyes, Shari Pilon-Thomas, Stuart Ratner, Kuang-Chung Wei
Diversity Outbred Mice Reveal the Quantitative Trait Locus and Regulatory Cells of HER2 Immunity. Journal of immunology (Baltimore, Md. : 1950) 205 (6) (2020)
Hoyoung M Maeng, Jay A Berzofsky
Strategies for developing and optimizing cancer vaccines. F1000Research 8 (2019)